Developer docs
API playgroundTry for free, no card

Search company profiles

SofWave Medical

Full company profile

uuid0000al1

Namestring
SofWave Medical
Legal namestring
Sofwave Medical Ltd.
Websiteurl
sofwave.com
Company typeenum
Public
Founded yearint
2015
Descriptiontext

SofWave Medical Ltd. is a publicly traded (NASDAQ: SFBX) Israeli medical aesthetics company founded in 2015 and headquartered in Yokne'am Illit, Israel, with a UK representative office in London. The company develops and commercializes non-invasive, FDA-cleared energy-based devices for dermatologists, plastic surgeons, medical spas, and aesthetic clinics. Its core product, the Sofwave™ system, uses proprietary SUPERB™ (Synchronous Ultrasound Parallel Beam) technology to deliver ultrasound energy through parallel beams that stimulate production of collagen, elastin, and hyaluronic acid in the skin. An integrated SofCool™ mechanism protects the epidermis during treatment. The company complements the ultrasound platform with PureImpact VIP, an FDA-cleared electrical muscle stimulation device that uses 3-directional stimulation to emulate plyometric exercise for muscle toning, and the liftHD™ Body Applicator, a redesigned ergonomic handpiece optimized for body contouring treatments.

Sofwave generates revenue through two complementary streams: capital equipment sales of its Sofwave and PureImpact systems to aesthetic providers, and recurring usage-based revenue from consumable "pulses" purchased through the Sofwave E-Store that providers consume during patient treatments. The company sells and supports its installed base via a direct sales force, practice development managers, and clinical education programs, and operates a Peak Advantage Partners ecosystem that includes the PulsePal patient loyalty program and a mobile app for provider training, marketing assets, and pulse purchasing. Q4 2025 revenue reached $28.9 million (+58% year-over-year) and full-year 2025 revenue totaled $87.6 million, marking the company's first full year of net profitability. Sofwave positions itself around the GLP-1 weight loss patient cohort, where rapid weight loss creates downstream demand for skin tightening and body contouring.

Short descriptiontext

SofWave Medical is an Israeli medical aesthetics company that develops and sells FDA-cleared, non-invasive ultrasound and EMS devices (Sofwave, PureImpact VIP) to dermatologists, plastic surgeons, and med-spas for skin lifting, wrinkle reduction, body contouring, and muscle toning.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersYoqne`am `illit, Israel
HQ citystring
Yoqne`am `illit
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
aesthetic medical devices, non-invasive skin rejuvenation, ultrasound aesthetic technology, EMS muscle stimulation, energy-based aesthetics
Industry3 codes
1Laser & Energy-Based Dermatology
CodeHLAKACAFPrimaryYes
2Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser)
CodeHLAHADACPrimaryNo
3Skincare Devices (Cleansing Brushes, Microcurrent, LED, Dermaplaning)
CodeCRABAKAIPrimaryNo
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
  • Medical Equipment and Supplies Manufacturing3391
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Aesthetic Medical Devices
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Device/System Sales
TypeHardware Sales
Description

Sofwave sells its ultrasound and EMS devices to aesthetic medical providers including dermatologists, plastic surgeons, and med-spas. The company generates revenue from initial system placements to clinics.

in.investing.com
2Consumables (Pulses)
TypeUsage Based
Description

Revenue from consumable 'pulses' used during treatments. Providers purchase pulses through the Sofwave e-store. This creates a recurring revenue stream tied to treatment volume.

estore.sofwave.com
3Treatment Utilization Fees
TypeUsage Based
Description

Q4 2025 revenue growth driven by increased treatment utilization and ongoing usage fees, indicating recurring revenue from clinical usage of installed systems.

in.investing.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Technology or R&D, Marketing or Sales, Personnel, Operations
Pricing details1 tier
1Pulse packages for treatment consumables
ModelUsage-basedBilling cadencePay-as-you-go
Notes

Pulses and hours packages available for purchase through the e-store. Note: Cannot add Pulses & Hours packages to same cart.

estore.sofwave.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1SUPERB™
Description

Proprietary synchronous ultrasound parallel beam technology for non-invasive skin treatments that stimulates collagen, elastin, and hyaluronic acid production.

sofwave.com
+4 more records
Core offering1 text field

SofWave Medical designs, manufactures, and sells FDA-cleared, non-invasive energy-based aesthetic medical devices — primarily the Sofwave™ ultrasound platform (using proprietary SUPERB™ technology for skin lifting, tightening, wrinkle reduction, cellulitis, and acne scar treatment) and the PureImpact VIP electrical muscle stimulation device for body muscle toning. The company sells devices directly to dermatologists, plastic surgeons, medical spas, and aesthetic clinics, and generates recurring revenue through consumable "pulses" purchased by providers for each treatment.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

SofWave Medical operates as a medical aesthetic device company offering a unified platform of non-invasive energy-based solutions. The core portfolio consists of two FDA-cleared technology systems: Sofwave™ using proprietary SUPERB™ ultrasound technology for skin lifting, tightening, and rejuvenation; and PureImpact VIP using electrical muscle stimulation (EMS) for body toning and muscle strengthening. These core systems are supported by the liftHD™ Body Applicator (body treatment handpiece), the Peak Advantage Partners mobile app (provider portal with marketing, training, and support tools), the PulsePal loyalty program, and the Sofwave E-Store for purchasing treatment consumables. The company positions itself as 'The Regenerative Aesthetics Company™,' targeting aesthetic clinics, dermatologists, and medical spas seeking non-invasive face and body treatment solutions.

Product and service4 records
1Sofwave™ Ultrasound System (SUPERB™ Technology)
CategoryAesthetic medical devices — energy-based ultrasound platform
Description

Non-invasive ultrasound platform using proprietary SUPERB™ technology to stimulate collagen, elastin, and hyaluronic acid production for skin lifting, tightening, and rejuvenation. FDA-cleared for facial lines and wrinkles, eyebrow lift, submental/neck tissue laxity, upper arms, short-term improvement in appearance of cellulitis, and treatment of acne scars in subjects aged 22 and older. Sold to aesthetic medical providers including dermatologists, plastic surgeons, and med-spas.

2PureImpact VIP EMS Device
CategoryAesthetic medical devices — electrical muscle stimulation
Description

FDA-cleared electrical muscle stimulation (EMS) device for strengthening, toning, and firming muscles in the abdomen, thighs, buttocks, and arms. Uses proprietary 3-directional stimulation technology designed to emulate real plyometric exercises and support long-term muscle progress. Sold to aesthetic medical providers for use in body contouring and muscle toning treatments.

3liftHD™ Body Applicator
CategoryAesthetic medical devices — applicator/accessory hardware
Description

Redesigned ergonomic handpiece accessory for the Sofwave ultrasound system designed for body treatments beyond the face. Features increased transducer size for enhanced heating efficiency with larger thermal zones and integrated SofCool™ technology for patient comfort and safety. Sold to existing Sofwave provider customers.

4Sofwave E-Store
CategoryE-commerce / consumables platform
Description

Online commerce storefront at estore.sofwave.com through which contracted providers purchase consumable pulse packages (treatment credits) and electrode pads for PureImpact devices. Provides the recurring usage-based revenue stream tied to clinical treatment volume.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeOthersAnnounced on2026-04-04
Description

Pure Impact VIP is Sofwave's proprietary electrical muscle stimulation (EMS) technology product line. Sofwave hosts the PEAK Advantage Partnership Summit featuring Pure Impact technology alongside Sofwave ultrasound treatments for the provider network.

2Peak Advantage Partner Providers
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-04
Description

Network of aesthetic medical providers (dermatologists, plastic surgeons, med-spas) who are contracted to provide Sofwave treatments. The company hosts annual partnership summit to train and support these providers.

einpresswire.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Cutera is a direct peer in the energy-based aesthetic device space, offering laser, IPL, and RF systems (e.g., truSculpt, Secret RF) to dermatologists and med-spas. Both companies compete for the same provider budget and patient indications around skin rejuvenation and body contouring.

TypeDirect peer
Description

InMode is a direct peer in non-invasive aesthetic devices, with platforms (BodyTite, Morpheus8, Evoke) covering face and body contouring. Both companies sell energy-based systems to aesthetic providers with similar recurring consumable economics.

TypeDirect peer
Description

BTL is a direct peer in non-invasive body contouring with the Emsculpt EMS device family, directly overlapping Sofwave's PureImpact VIP product line. Both target the same muscle-toning/body-contouring use case for med-spas and aesthetic clinics.

TypeBroad incumbent
Description

Solta Medical, part of Bausch Health, is a broad incumbent in energy-based aesthetics with Thermage (RF) and Fraxel (laser) platforms. Competes with Sofwave's ultrasound approach across skin tightening and rejuvenation indications.

TypeBroad incumbent
Description

Cynosure is a broad incumbent offering laser, RF, and body contouring devices (TempSure, Mona Lisa Touch) to the same aesthetic provider base as Sofwave, with overlapping skin and body treatment indications.

TypeBroad incumbent
Description

Alma Lasers is a broad incumbent in energy-based aesthetic devices, offering Accent, Soprano, and Harmony platforms covering skin tightening, body contouring, and hair removal—competing with Sofwave across multiple provider indications.

TypeBroad incumbent
Description

Sciton is a broad incumbent offering laser and light-based platforms (BBL, Halo, Profractional) targeting dermatologists and plastic surgeons. Competes with Sofwave on skin rejuvenation and resurfacing indications in the same provider channel.

TypeBroad incumbent
Description

Merz Aesthetics is a broad incumbent in medical aesthetics (Ultherapy HIFU, Radiesse fillers, Xeomin). Ultherapy directly competes with Sofwave in non-invasive skin lifting, while Merz's broader portfolio targets the same provider customers.

TypeBroad incumbent
Description

Candela Medical is a broad incumbent in energy-based aesthetic and medical devices (GentleLase, Profound, PicoWay), selling laser and RF platforms to the same aesthetic provider base as Sofwave.

TypeEmerging player
Description

Evolus is an emerging player in aesthetics focused on injectable neurotoxins (Jeuveau), serving the same med-spa and dermatology channels as Sofwave. While the modality differs, Evolus competes for the same provider relationship and patient wallet share for non-invasive aesthetic treatments.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers13 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SofWave Medical

Aesthetic Medical Devicessofwave.com

SofWave Medical is an Israeli medical aesthetics company that develops and sells FDA-cleared, non-invasive ultrasound and EMS devices (Sofwave, PureImpact VIP) to dermatologists, plastic surgeons, and med-spas for skin lifting, wrinkle reduction, body contouring, and muscle toning.

What SofWave Medical does

SofWave Medical Ltd. is a publicly traded (NASDAQ: SFBX) Israeli medical aesthetics company founded in 2015 and headquartered in Yokne'am Illit, Israel, with a UK representative office in London. The company develops and commercializes non-invasive, FDA-cleared energy-based devices for dermatologists, plastic surgeons, medical spas, and aesthetic clinics. Its core product, the Sofwave™ system, uses proprietary SUPERB™ (Synchronous Ultrasound Parallel Beam) technology to deliver ultrasound energy through parallel beams that stimulate production of collagen, elastin, and hyaluronic acid in the skin. An integrated SofCool™ mechanism protects the epidermis during treatment. The company complements the ultrasound platform with PureImpact VIP, an FDA-cleared electrical muscle stimulation device that uses 3-directional stimulation to emulate plyometric exercise for muscle toning, and the liftHD™ Body Applicator, a redesigned ergonomic handpiece optimized for body contouring treatments.

Sofwave generates revenue through two complementary streams: capital equipment sales of its Sofwave and PureImpact systems to aesthetic providers, and recurring usage-based revenue from consumable "pulses" purchased through the Sofwave E-Store that providers consume during patient treatments. The company sells and supports its installed base via a direct sales force, practice development managers, and clinical education programs, and operates a Peak Advantage Partners ecosystem that includes the PulsePal patient loyalty program and a mobile app for provider training, marketing assets, and pulse purchasing. Q4 2025 revenue reached $28.9 million (+58% year-over-year) and full-year 2025 revenue totaled $87.6 million, marking the company's first full year of net profitability. Sofwave positions itself around the GLP-1 weight loss patient cohort, where rapid weight loss creates downstream demand for skin tightening and body contouring.

SofWave Medical firmographics

Firmographics
Name
SofWave Medical
Legal name
Sofwave Medical Ltd.
Website
https://sofwave.com
Company type
Public
Founded year
2015
Operating status
Operating
Headcount range
101–250 employees
Short description
SofWave Medical is an Israeli medical aesthetics company that develops and sells FDA-cleared, non-invasive ultrasound and EMS devices (Sofwave, PureImpact VIP) to dermatologists, plastic surgeons, and med-spas for skin lifting, wrinkle reduction, body contouring, and muscle toning.
Ownership category
akta.pro rank

SofWave Medical industry classification

Industry
Product category
Aesthetic Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Laser & Energy-Based Dermatology (HLAKACAF)
akta.pro secondary industries
Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser) (HLAHADAC), Skincare Devices (Cleansing Brushes, Microcurrent, LED, Dermaplaning) (CRABAKAI)

Keywords

  • Aesthetic medical devices
  • Non-invasive skin rejuvenation
  • Ultrasound aesthetic technology
  • EMS muscle stimulation
  • Energy-based aesthetics

Where SofWave Medical is headquartered

Location

Headquarters

HQ city
Yoqne`am `illit
HQ country
Israel
HQ region
Middle East

Offices2 records

Markets served

SofWave Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Marketing or Sales, Personnel, Operations

Revenue model

  1. Device/System Sales: Sofwave sells its ultrasound and EMS devices to aesthetic medical providers including dermatologists, plastic surgeons, and med-spas. The company generates revenue from initial system placements to clinics.
  2. Consumables (Pulses): Revenue from consumable 'pulses' used during treatments. Providers purchase pulses through the Sofwave e-store. This creates a recurring revenue stream tied to treatment volume.
  3. Treatment Utilization Fees: Q4 2025 revenue growth driven by increased treatment utilization and ongoing usage fees, indicating recurring revenue from clinical usage of installed systems.

Pricing tiers

ModelBillingPrice
Usage-basedPay-as-you-goPulse packages for treatment consumables

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

SofWave Medical product offering

Product offering

Core offering

SofWave Medical designs, manufactures, and sells FDA-cleared, non-invasive energy-based aesthetic medical devices — primarily the Sofwave™ ultrasound platform (using proprietary SUPERB™ technology for skin lifting, tightening, wrinkle reduction, cellulitis, and acne scar treatment) and the PureImpact VIP electrical muscle stimulation device for body muscle toning. The company sells devices directly to dermatologists, plastic surgeons, medical spas, and aesthetic clinics, and generates recurring revenue through consumable "pulses" purchased by providers for each treatment.

Product overview

SofWave Medical operates as a medical aesthetic device company offering a unified platform of non-invasive energy-based solutions. The core portfolio consists of two FDA-cleared technology systems: Sofwave™ using proprietary SUPERB™ ultrasound technology for skin lifting, tightening, and rejuvenation; and PureImpact VIP using electrical muscle stimulation (EMS) for body toning and muscle strengthening. These core systems are supported by the liftHD™ Body Applicator (body treatment handpiece), the Peak Advantage Partners mobile app (provider portal with marketing, training, and support tools), the PulsePal loyalty program, and the Sofwave E-Store for purchasing treatment consumables. The company positions itself as 'The Regenerative Aesthetics Company™,' targeting aesthetic clinics, dermatologists, and medical spas seeking non-invasive face and body treatment solutions.

Differentiator

Problem solved

Functional benefit

Brands

  • SUPERB™: Proprietary synchronous ultrasound parallel beam technology for non-invasive skin treatments that stimulates collagen, elastin, and hyaluronic acid production.
  • PureImpact VIP
  • liftHD™
  • Plyopulse
  • Peak Advantage Partners

Products and services

  • Sofwave™ Ultrasound System (SUPERB™ Technology) Non-invasive ultrasound platform using proprietary SUPERB™ technology to stimulate collagen, elastin, and hyaluronic acid production for skin lifting, tightening, and rejuvenation. FDA-cleared for facial lines and wrinkles, eyebrow lift, submental/neck tissue laxity, upper arms, short-term improvement in appearance of cellulitis, and treatment of acne scars in subjects aged 22 and older. Sold to aesthetic medical providers including dermatologists, plastic surgeons, and med-spas.
  • PureImpact VIP EMS Device FDA-cleared electrical muscle stimulation (EMS) device for strengthening, toning, and firming muscles in the abdomen, thighs, buttocks, and arms. Uses proprietary 3-directional stimulation technology designed to emulate real plyometric exercises and support long-term muscle progress. Sold to aesthetic medical providers for use in body contouring and muscle toning treatments.
  • liftHD™ Body Applicator Redesigned ergonomic handpiece accessory for the Sofwave ultrasound system designed for body treatments beyond the face. Features increased transducer size for enhanced heating efficiency with larger thermal zones and integrated SofCool™ technology for patient comfort and safety. Sold to existing Sofwave provider customers.
  • Sofwave E-Store Online commerce storefront at estore.sofwave.com through which contracted providers purchase consumable pulse packages (treatment credits) and electrode pads for PureImpact devices. Provides the recurring usage-based revenue stream tied to clinical treatment volume.

Companies that use SofWave Medical

Customer profile

Named customers13 records

Segments3 records

Ideal customer profiles1 record

SofWave Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

SofWave Medical partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Pure Impact (Sofwave Product Line)coreOthers · 4 April 2026Pure Impact VIP is Sofwave's proprietary electrical muscle stimulation (EMS) technology product line. Sofwave hosts the PEAK Advantage Partnership Summit featuring Pure Impact technology alongside Sofwave ultrasound treatments for the provider network.
  • Peak Advantage Partner ProviderscoreChannel Partner/ Reseller/ Distributor · 4 April 2026Network of aesthetic medical providers (dermatologists, plastic surgeons, med-spas) who are contracted to provide Sofwave treatments. The company hosts annual partnership summit to train and support these providers.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

SofWave Medical competitors and assessment

Company assessment

Direct peers

  • Cutera: Cutera is a direct peer in the energy-based aesthetic device space, offering laser, IPL, and RF systems (e.g., truSculpt, Secret RF) to dermatologists and med-spas. Both companies compete for the same provider budget and patient indications around skin rejuvenation and body contouring.
  • InMode Ltd. InMode is a direct peer in non-invasive aesthetic devices, with platforms (BodyTite, Morpheus8, Evoke) covering face and body contouring. Both companies sell energy-based systems to aesthetic providers with similar recurring consumable economics.
  • BTL Industries (Emsculpt): BTL is a direct peer in non-invasive body contouring with the Emsculpt EMS device family, directly overlapping Sofwave's PureImpact VIP product line. Both target the same muscle-toning/body-contouring use case for med-spas and aesthetic clinics.

Broad incumbents

  • Solta Medical (Bausch Health): Solta Medical, part of Bausch Health, is a broad incumbent in energy-based aesthetics with Thermage (RF) and Fraxel (laser) platforms. Competes with Sofwave's ultrasound approach across skin tightening and rejuvenation indications.
  • Cynosure (HEALEON): Cynosure is a broad incumbent offering laser, RF, and body contouring devices (TempSure, Mona Lisa Touch) to the same aesthetic provider base as Sofwave, with overlapping skin and body treatment indications.
  • Alma Lasers: Alma Lasers is a broad incumbent in energy-based aesthetic devices, offering Accent, Soprano, and Harmony platforms covering skin tightening, body contouring, and hair removal—competing with Sofwave across multiple provider indications.
  • Sciton: Sciton is a broad incumbent offering laser and light-based platforms (BBL, Halo, Profractional) targeting dermatologists and plastic surgeons. Competes with Sofwave on skin rejuvenation and resurfacing indications in the same provider channel.
  • Merz Aesthetics: Merz Aesthetics is a broad incumbent in medical aesthetics (Ultherapy HIFU, Radiesse fillers, Xeomin). Ultherapy directly competes with Sofwave in non-invasive skin lifting, while Merz's broader portfolio targets the same provider customers.
  • Candela Medical: Candela Medical is a broad incumbent in energy-based aesthetic and medical devices (GentleLase, Profound, PicoWay), selling laser and RF platforms to the same aesthetic provider base as Sofwave.

Emerging players

  • Evolus: Evolus is an emerging player in aesthetics focused on injectable neurotoxins (Jeuveau), serving the same med-spa and dermatology channels as Sofwave. While the modality differs, Evolus competes for the same provider relationship and patient wallet share for non-invasive aesthetic treatments.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

SofWave Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SofWave Medical leadership team

Management profile

Number of profiles

Profiles5 records

SofWave Medical funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SofWave Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SofWave Medical

What does SofWave Medical do?

SofWave Medical designs, manufactures, and sells FDA-cleared, non-invasive energy-based aesthetic medical devices — primarily the Sofwave™ ultrasound platform (using proprietary SUPERB™ technology for skin lifting, tightening, wrinkle reduction, cellulitis, and acne scar treatment) and the PureImpact VIP electrical muscle stimulation device for body muscle toning. The company sells devices directly to dermatologists, plastic surgeons, medical spas, and aesthetic clinics, and generates recurring revenue through consumable "pulses" purchased by providers for each treatment.

Is SofWave Medical a public or private company?

SofWave Medical is a public company. It is classified as public and is currently operating.

When was SofWave Medical founded?

SofWave Medical was founded in 2015. It employs 101 to 250 people.

Where is SofWave Medical based?

SofWave Medical is headquartered in Yoqne`am `illit, Israel, in the Middle East region.

How does SofWave Medical make money?

Three revenue lines are on record. Device/System Sales are the primary driver. The others are consumables (Pulses) and treatment Utilization Fees.

Who are SofWave Medical's main competitors?

Direct peers on record are Cutera, InMode Ltd. and BTL Industries (Emsculpt). Broad incumbents are Solta Medical (Bausch Health), Cynosure (HEALEON), Alma Lasers, Sciton, Merz Aesthetics and Candela Medical. Evolus is listed as an emerging player.

Does SofWave Medical have an API?

No public API is recorded for SofWave Medical.

What industry is SofWave Medical in?

SofWave Medical's product category is Aesthetic Medical Devices. Its primary akta.pro industry code is HLAKACAF, Laser & Energy-Based Dermatology, with a secondary code of HLAHADAC, Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinancialContent Business PageNew Study on Sofwave's Pure Impact Adds to a Growing Case for Treating the Body After Weight LossSofwave published a blank-controlled trial of its Pure Impact VIP platform, which delivered PlyoPulse electrical muscle stimulation to 38 adults. The study found 68% improvement in prone hip extension and 73% in side plank endurance by week five, with gains sustained at week nine. The company's other device targets skin laxity, not muscle.YahooSofwave Medical Reports Second Quarter and First Half 2026 Financial Results and Business HighlightsSofWave Medical Ltd reported its financial results for the second quarter and first half of 2026, showing strong revenue growth and improved profitability. The company highlighted its expanding installed base, increasing treatments, and rising demand for regenerative aesthetic treatments.GlobeNewswireSofwave Medical Reports Second Quarter and First Half 2026 Financial Results and Business HighlightsSofwave Medical Ltd reported its financial results for the second quarter and first half of fiscal year 2026, showing year-over-year growth in revenue, gross margin, and net income. The company sold approximately 3,100 systems and conducted over 975,000 treatments since commercialization, with a positive outlook on demand and profitability.GlobeNewswireSofwave to Participate in 11th Annual Needham Virtual MedTech & Diagnostics 1x1 ConferenceSofwave Medical Ltd (TASE: SOFW), an energy-based non-invasive aesthetic medical device company, announced that CEO Louis Scafuri and CFO Assaf Korner will participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference on August 10–11, 2026. The conference is a virtual event focused on the medtech and diagnostics sector, providing a platform for one-on-one meetings between company executives and investors. The company's flagship technology SUPERB (Synchronous Ultrasound Parallel Beam) is FDA-cleared for facial wrinkle reduction, skin lifting, and treatment of acne scars and cellulitis.Business Wire BlogAlix Earle, Hilary Duff, Nicole Williams English and Tiffany Haddish Revealed as Sports Illustrated Swimsuit’s 2026 Cover ModelsSports Illustrated Swimsuit announced its 2026 issue, featuring Alix Earle, Hilary Duff, Nicole Williams English, and Tiffany Haddish as cover models. The issue includes over 30 women and will be available on select newsstands May 14 and nationally May 26.GlobeNewswireSofwave Medical Reports First Quarter Fiscal 2026 Financial Results and Business HighlightsSofwave Medical reported Q1 2026 revenue of $24.4M, up 46% year-over-year, with usage fee revenue of $11.0M, up 56%. The company posted IFRS net income of $1.3M versus a $1.1M loss in the prior year. Cash and cash equivalents stood at $35.1M as of March 31, 2026.TechBullionPeer-Reviewed Study Shows Clinical Improvement in Cellulite & Skin Laxity Using Sofwave UltrasoundA peer-reviewed study published in the Journal of Cosmetic Dermatology (2025) demonstrated statistically significant improvements in the appearance of cellulose and skin laxity using Sofwave's synchronous parallel ultrasound technology in a U.S. multicenter clinical trial of 60 female participants. The trial found 91% of treated areas showed visible improvement based on blinded assessments, alongside a 69% average reduction in cellulose severity and 53% improvement in skin laxity compared with baseline. The findings add to clinical evidence supporting non-invasive ultrasound approaches in aesthetic medicine, with the technology positioned as a treatment option for patients experiencing skin changes following rapid weight loss, including those associated with GLP-1 medications.openPR.comPeer-Reviewed Study Shows Clinical Improvement in Cellulite and Skin Laxity Using Sofwave Ultrasound TechnologyA peer-reviewed study published in the Journal of Cosmetic Dermatology (2025) found statistically significant improvements in the appearance of Cellulite and skin laxity following treatment with Sofwave's synchronous parallel ultrasound technology, based on a prospective multicenter U.S. clinical trial involving 60 female participants across five investigational sites. Results showed 91% of treated areas had visible improvement based on blinded assessments, along with a 69% average reduction in Cellulite severity and 53% improvement in skin laxity; 73% of patients reported satisfaction with no serious adverse events observed. Sofwave, the medical aesthetics company behind the technology, cited the findings as providing an objective framework for assessing treatment outcomes, while researchers noted further studies are needed to understand long-term outcomes across broader populations.Investing.comSofwave Q4 2025 slides: 58% revenue surge, profitability milestone By Investing.comSofwave Medical Ltd reported Q4 2025 revenue of $28.9 million, a 58% year-over-year increase, marking its strongest quarterly performance and the company's first full year of profitability with IFRS net income of $5.5 million. The Israeli aesthetic device company, which specializes in non-invasive ultrasound skin tightening treatments, saw its stock rise 7.02% to $37.77 following the results, capping a 129% gain over the past year. The company highlighted strategic positioning to capitalize on GLP-1 weight loss drug adoption, noting that 63% of GLP-1 patients seeking aesthetic procedures are new to the industry and often require skin tightening treatments due to resulting skin laxity.Investing.comEarnings call transcript: Sofwave Medical Q4 2025 sees 58% revenue growth By Investing.comSofwave Medical Ltd. reported Q4 2025 revenue of $28.9 million, a 58% year-over-year increase, driven by its transition to a recurring revenue model where ongoing usage fees now represent 43% of total revenue. The company achieved $4.1 million in IFRS net income and an all-time high operating income of $4.6 million for the quarter, while full-year 2025 revenue reached $87.6 million, up 47% from 2024. Sofwave also expanded its global footprint to over 52 countries, with new products liftHD and Pure Impact VIP targeting the growing body aesthetics market, particularly patients using GLP-1 weight loss medications.